Publication:
European Neuroendocrine Tumour Society (ENETS) 2023 guidance paper for nonfunctioning pancreatic neuroendocrine tumours.

cris.virtual.author-orcid0000-0002-6819-6092
cris.virtualsource.author-orcid3ec0027b-2673-414b-8349-5980812773b3
datacite.rightsopen.access
dc.contributor.authorKos-Kudła, Beata
dc.contributor.authorCastaño, Justo P
dc.contributor.authorDenecke, Timm
dc.contributor.authorGrande, Enrique
dc.contributor.authorKjaer, Andreas
dc.contributor.authorKoumarianou, Anna
dc.contributor.authorde Mestier, Louis
dc.contributor.authorPartelli, Stefano
dc.contributor.authorPerren, Aurel
dc.contributor.authorStättner, Stefan
dc.contributor.authorValle, Juan W
dc.contributor.authorFazio, Nicola
dc.date.accessioned2024-10-25T18:22:59Z
dc.date.available2024-10-25T18:22:59Z
dc.date.issued2023-12
dc.description.abstractThis ENETS guidance paper for well-differentiated nonfunctioning pancreatic neuroendocrine tumours (NF-Pan-NET) has been developed by a multidisciplinary working group, and provides up-to-date and practical advice on the management of these tumours. Using the extensive experience of centres treating patients with NF-Pan-NEN, the authors of this guidance paper discuss 10 troublesome questions in everyday clinical practice. Our many years of experience in this field are still being verified in the light of the results of new clinical, which set new ways of proceeding in NEN. The treatment of NF-Pan-NEN still requires a decision of a multidisciplinary team of specialists in the field of neuroendocrine neoplasms.
dc.description.sponsorshipInstitut für Gewebemedizin und Pathologie
dc.identifier.doi10.48350/187443
dc.identifier.pmid37877341
dc.identifier.publisherDOI10.1111/jne.13343
dc.identifier.urihttps://boris-portal.unibe.ch/handle/20.500.12422/170870
dc.language.isoen
dc.publisherWiley-Blackwell
dc.relation.ispartofJournal of neuroendocrinology
dc.relation.issn0953-8194
dc.relation.organizationDCD5A442BE2AE17DE0405C82790C4DE2
dc.relation.organizationDCD5A442BF89E17DE0405C82790C4DE2
dc.subjectdiagnostics guideline neuroendocrine tumour pancreatic nonfunctioning neuroendocrine tumour treatment
dc.subject.ddc500 - Science::570 - Life sciences; biology
dc.subject.ddc600 - Technology::610 - Medicine & health
dc.titleEuropean Neuroendocrine Tumour Society (ENETS) 2023 guidance paper for nonfunctioning pancreatic neuroendocrine tumours.
dc.typearticle
dspace.entity.typePublication
dspace.file.typetext
oaire.citation.issue12
oaire.citation.startPagee13343
oaire.citation.volume35
oairecerif.author.affiliationInstitut für Gewebemedizin und Pathologie
oairecerif.author.affiliation2Institut für Gewebemedizin und Pathologie - Klinische Pathologie
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.date.licenseChanged2023-10-27 04:57:22
unibe.description.ispublishedpub
unibe.eprints.legacyId187443
unibe.journal.abbrevTitleJ NEUROENDOCRINOL
unibe.refereedtrue
unibe.subtype.articlereview

Files

Original bundle
Now showing 1 - 1 of 1
Name:
J_Neuroendocrinology_-_2023_-_Kos_Kud_a_-_European_Neuroendocrine_Tumour_Society_ENETS_2023_guidance_paper_for.pdf
Size:
1.67 MB
Format:
Adobe Portable Document Format
File Type:
text
License:
https://creativecommons.org/licenses/by-nc/4.0
Content:
published

Collections